Solazyme in the Stock Market
Sources reveal that Solazyme reported a net loss of $14.09 million for the quarter, a bigger net loss than the $8.92 million it reported in 2010. In the first week of November, the company reported revenues of $8.94 million, up from revenues of $4.63 million. Solazyme’s shares have been down over the three-month period, and as of November 13th, 2011 , its shares were trading at $11.16.
To know more about the status of some biofuel and biochemical firms’ earnings and current stock prices, please follow this link – http://gigaom.com/cleantech/the-state-of-biofuels-and-the-public-markets/ . More about Solazyme from here : http://www.solazyme.com/
Leave a Reply
| | posted by Sumukhi Sreevatsan
